Abstract Details
|
Alexander Junxiang Chen
PRESENTER |
Mr. Chen has nothing to disclose. |
| Cheick O. Soumah, Sr., MD | Dr. Soumah has nothing to disclose. |
| Malé Dore, MD, PhD | Dr. Dore has nothing to disclose. |
| NEDOUMBAYEL NAITORMBAIDE Gysèle II, MD | Dr. Gysèle has nothing to disclose. |
| Oumar Mara, MD | Dr. Mara has nothing to disclose. |
| DESIRE D. NELDJE, Jr., MD | Dr. NELDJE has nothing to disclose. |
| Seungwon Lee, BA | Miss Lee has nothing to disclose. |
| Nomin Enkhtsetseg | Ms. Enkhtsetseg has nothing to disclose. |
| Siddharth Satish, Student | Mr. Satish has nothing to disclose. |
| Maya Mastick | Ms. Mastick has nothing to disclose. |
| Isabella Gomez Hjerthen | No disclosure on file |
| Farrah J. Mateen, MD, PhD, FAAN (Northwestern University Department of Neurology) | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |
| FODE ABASS CISSE, MD | Dr. CISSE has nothing to disclose. |